Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2006) 11 P891

ECE2006 Poster Presentations Thyroid (174 abstracts)

Regulation of fibroblast growth factor receptor-1 (FGFR1) by thyroid hormone (T3): identification of a thyroid hormone response element (TRE) in the murine Fgfr1 promoter

PJ O’Shea 1 , GR Williams 2 & SY Cheng 1


1Gene Regulation Section, Laboratory of Molecular Biology, National Cancer Institute, NIH, Bethesda, MD 20892, United States; 2Molecular Endocrinology Group, Division of Medicine and MRC Clinical Sciences Centre, Imperial College London, London, W12 0NN, United Kingdom.


T3 is essential for skeletal development and T3-actions in bone are mediated mainly by the nuclear receptor TRα1. We previously identified that FGFR1 is a T3-responsive gene in osteoblasts by subtraction hybridization. In mice that harbor a dominant negative mutation PV, FGFR1 mRNA expression is reduced in TRα1PV mutants that exhibit skeletal hypothyroidism and increased in TRβPV/PV mice with skeletal thyrotoxicosis. In this study, primary calvarial osteoblasts from wild-type and TRβPV/PV littermates were cultured in the absence and presence of T3. Quantitative RT-PCR revealed FGFR1 mRNA expression was increased 25-fold in TRβPV/PV osteoblasts relative to wild-type cells maintained in T3, but elevated only 2.3-fold in the absence of T3. These data indicate that, although FGFR1 mRNA expression is increased in TRβPV/PV osteoblasts in the absence and presence of hormone, the mutant cells remain exquisitely sensitive to T3, demonstrating that T3-action in TRβPV/PV osteoblasts is mediated via the unaffected TRα1 protein. We next performed electrophoretic mobility shift assays to identify and characterize a TRE between positions −279/−264 of the Fgfr1 promoter that showed strong and specific binding with TR/RXR heterodimers but weaker specific binding with TR/TR homodimers. Mutational analysis of the putative binding site attenuated TR/RXR and TR/TR specific binding and confirmed the identity of the TRE, which consisted of a classical direct repeat-4 (DR4) motif. We further performed transient transfection studies using T3-treated CV-1 cells co-transfected with TRα1 or TRβ1 and a range of CAT-reporter gene constructs linked to 5′-deletion mutants of the Fgfr1 gene 5′-flanking region. Initial results indicate that truncation of the Fgfr1 5′-flanking region containing the putative TRE leads to a loss of T3-responsiveness without affecting basal promoter activity. These data indicate that the effects of T3 in the skeleton are mediated, at least in part, via TRα1-dependent transcriptional regulation of FGFR1 expression.

Volume 11

8th European Congress of Endocrinology incorporating the British Endocrine Societies

European Society of Endocrinology 
British Endocrine Societies 

Browse other volumes

Article tools

My recent searches

No recent searches.